22157.jpg
AI in Drug Discovery Strategic Intelligence Research Report 2024: Healthcare, Macroeconomic, Technology, and Regulatory Trends Impacts
December 20, 2024 09:49 ET | Research and Markets
Dublin, Dec. 20, 2024 (GLOBE NEWSWIRE) -- The "Strategic Intelligence: AI in drug discovery" report has been added to ResearchAndMarkets.com's offering. This report consolidates the latest...
22157.jpg
AI-based Drug Repurposing Global Market Report 2024 - How AI-based Drug Repurposing Is Superior to Traditional Drug Discovery
October 21, 2024 11:11 ET | Research and Markets
Dublin, Oct. 21, 2024 (GLOBE NEWSWIRE) -- The "AI-based Drug Repurposing Market, Growth Opportunities, Global, 2024-2029" report has been added to ResearchAndMarkets.com's offering.This study...
tb_pressreleaselogo.png
Taglich Brothers Initiates Coverage of Cosmos Health Inc.
February 21, 2024 09:30 ET | Taglich Brothers Inc
Taglich Brothers, Inc. announces that it has initiated coverage of Cosmos Health Inc. (NASDAQ: COSM).
lifearc logo.png
LifeArc announces £5 million drug repurposing programme for motor neuron disease
December 06, 2023 02:00 ET | LifeArc
MEDIA RELEASE LifeArc announces £5 million drug repurposing programme for motor neuron disease LifeArc is launching new £5m programme to help find new treatments for motor neuron disease (MND).The...
Algernon Logo 1.png
Algernon Pharmaceuticals Receives Japanese Patent Notice of Allowance for Treatment of NASH with Repirinast
November 08, 2023 07:00 ET | Algernon Pharmaceuticals
VANCOUVER, British Columbia, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) a clinical stage pharmaceutical...
Global AI in Drug Discovery Market
Global Artificial Intelligence in Drug Discovery Market Research Report 2023: Partnerships and Mergers Between Sectors Presents Lucrative Opportunities - Forecasts to 2028
August 31, 2023 08:58 ET | Research and Markets
Dublin, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The "Global Markets for Artificial Intelligence in Drug Discovery" report has been added to ResearchAndMarkets.com's offering. The current report will...
Proficient Market Insights Final Logo-01-01.png
Drug Repurposing Market 2023 Will Revenue to Cross reach US$ 30920 million by 2028 Research by Business Opportunities, Top Companies report covers, Market-specific challenges, consumption by Regional data
January 10, 2023 06:12 ET | Proficient Market Insights
Pune, Jan. 10, 2023 (GLOBE NEWSWIRE) -- "Drug Repurposing Market" research report focus on overall information that can help to take decisions on current market situation. Drug Repurposing Market...
Global Computer-Aided Drug Discovery Market
Computer-Aided Drug Discovery Global Market Report 2022: Demand for Novel Drugs to Treat CVD Conditions Fuels Growth
November 07, 2022 08:38 ET | Research and Markets
Dublin, Nov. 07, 2022 (GLOBE NEWSWIRE) -- The "Computer-Aided Drug Discovery Market By Type, By Therapeutic Area, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2030" report...
22157.jpg
Middle East Respiratory Syndrome Coronavirus S Protein Drugs Report 2022: Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
June 13, 2022 04:43 ET | Research and Markets
Dublin, June 13, 2022 (GLOBE NEWSWIRE) -- The "Middle East Respiratory Syndrome coronavirus S Protein Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key...
22157.jpg
Global Human SARS Coronavirus Spike Glycoprotein Drugs Development Research Report 2022: Identify and Track Emerging Players in the Market and their Portfolios
June 09, 2022 04:53 ET | Research and Markets
Dublin, June 09, 2022 (GLOBE NEWSWIRE) -- The "Human SARS coronavirus Spike Glycoprotein Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players"...